이스라엘 - 히브리어 - Ministry of Health

מעבדות חי בע"מ - אחות

이스라엘 - 히브리어 - Ministry of Health

medtronic - רופא

이스라엘 - 히브리어 - Ministry of Health

זוטל בע"מ - צוות טכני - מעבדות דיאגנוסטיות בבתי חולים וקופות חולים

이스라엘 - 히브리어 - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - lidocaine as hydrochloride; methylprednisolone acetate - תרחיף להזרקה - lidocaine as hydrochloride 10 mg/ml; methylprednisolone acetate 40 mg/ml - methylprednisolone, combinations - lidocaine - depo-medrol with lidocaine is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: - synovitis of osteoarthritis - rheumatoid arthritis - acute and subacute bursitis - acute gouty arthritis - epicondylitis - acute nonspecific tenosynovitis - post-traumatic osteoarthritis.

이스라엘 - 히브리어 - Ministry of Health

אינטרביוטי קוסמטיקס ישראל בעמ - אנטיפרספירנט

이스라엘 - 히브리어 - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

이스라엘 - 히브리어 - Ministry of Health

novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

이스라엘 - 히브리어 - Ministry of Health

novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.

이스라엘 - 히브리어 - Ministry of Health

ציטרוס בע"מ - מומחה - to reduce lung volume in order to improve lung function and quality of life in patients with advanced emphysema

이스라엘 - 히브리어 - Ministry of Health

a.m.i. technologies, ltd. - מומחה - to reduce lung volume in order to improve lung function and quality of life in patients with advanced emphysema